Artal Group’s Cartesian Therapeutics RNAC Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-304,554	Closed	-$8.23M	–	76
2024 Q2	$8.23M	Sell	304,554 -8,832,081	-97%	-$239M	0.21%	43
2024 Q1	$5.94M	Hold	9,136,635	–	–	0.15%	57
2023 Q4	$6.3M	Hold	9,136,635	–	–	0.21%	42
2023 Q3	$9.69M	Hold	9,136,635	–	–	0.42%	36
2023 Q2	$10.2M	Buy	9,136,635 +4,253,435	+87%	+$4.76M	0.32%	47
2023 Q1	$6.79M	Hold	4,883,200	–	–	0.4%	53
2022 Q4	$5.52M	Hold	4,883,200	–	–	0.31%	56
2022 Q3	$8.01M	Hold	4,883,200	–	–	0.34%	46
2022 Q2	$6.4M	Buy	4,883,200 +883,200	+22%	+$1.16M	0.34%	45
2022 Q1	$4.92M	Hold	4,000,000	–	–	0.21%	78
2021 Q4	$13M	Hold	4,000,000	–	–	0.35%	55
2021 Q3	$16.6M	Hold	4,000,000	–	–	0.37%	56
2021 Q2	$16.7M	Sell	4,000,000 -500,000	-11%	-$2.09M	0.34%	57
2021 Q1	$20.4M	Hold	4,500,000	–	–	0.36%	55
2020 Q4	$13.6M	Hold	4,500,000	–	–	0.29%	72
2020 Q3	$11.2M	Buy	4,500,000 +1,600,000	+55%	+$3.97M	0.27%	61
2020 Q2	$8.24M	Sell	2,900,000 -513,629	-15%	-$1.46M	0.23%	65
2020 Q1	$8.23M	Hold	3,413,629	–	–	0.35%	47
2019 Q4	$8.12M	Buy	3,413,629 +1,313,629	+63%	+$3.13M	0.31%	48
2019 Q3	$3.68M	Hold	2,100,000	–	–	0.15%	70
2019 Q2	$3.76M	Hold	2,100,000	–	–	0.15%	74
2019 Q1	$4.98M	Buy	2,100,000 +1,500,000	+250%	+$3.56M	0.2%	62
2018 Q4	$1.6M	Buy	600,000 +38,460	+7%	+$102K	0.06%	72
2018 Q3	$8.73M	Buy	561,540 +61,540	+12%	+$957K	0.23%	39
2018 Q2	$6.63M	Buy	500,000 +375,000	+300%	+$4.97M	0.14%	40
2018 Q1	$1.27M	Buy	+125,000	New	+$1.27M	0.02%	73